Chris Wasden came to the digital therapeutics space via a circuitous route through Wall Street, Main Street, and academia. A pro at finding ways to leverage digital solutions in the pharmaceutical industry, he was asked to lead HappifyDTx’s digital therapeutics business after he and his students identified it as the best digital health company in the world. Happify just closed an impressive $73 million funding round and continues to innovate clinically validated tools to treat depression, anxiety, and sleep disorders.
In this episode, Chris tells Eugene how Happify’s founders moved from creating video games to digital health tools, and why the team took on the mammoth effort of creating an FDA-quality management system for its platform of products. As a result of their hard work, Chris says Happify is the only DTx company out there that has a legitimate, placebo-controlled RCT.
>>Click here to read the transcript
Guest Links and Resources:
Connect with Chris Wasden: LinkedIn | Twitter
Visit Happify Health: Twitter| LinkedIn | Facebook | Website
Host Links and Resources:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Follow Eugene's journey of writing his first book: Hard Pill to Swallow
Connect with YourCoach.health: Website | Twitter
Subscribe to Exits & Outcomes
Brian Dolan: Twitter | LinkedIn
HealthXL: Website | Twitter | Join an Event
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Thank you to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche
